FindTrial
Sign In

Effect of polyethylene glycol loxenatide treatment on body weight in patients with type 2 diabetes with different body mass index: a retrospective cohort study

Effect of polyethylene glycol loxenatide treatment on body weight in patients with type 2 diabetes with different body mass index: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087532
Enrollment
Unknown
Registered
2024-07-29
Start date
2024-07-30
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

polyethylene glycol loxenatide group:N/A
SGLT2i group:N/A

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Type 2 diabetes patients, age = 18 years; 2) Treatment with polyethylene glycol loxenatide or SGLT2i for at least 3-6 months

Exclusion criteria

Exclusion criteria: Type 1 diabetes

Design outcomes

Primary

MeasureTime frame
weight;—

Secondary

MeasureTime frame
body mass index;HbA1c;Fasting blood glucose;triglyceride;total cholesterol;HDL-C;HDL-C;Systolic blood pressure;Diastolic blood pressure;Proportion of participants who achieved 5% weight loss;Proportion of participants who achieved 10% weight loss;—

Countries

China

Contacts

Public ContactBenping Zhang

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology

benping86@163.com+86 158 7238 0868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026